Studies showed that factor Xa inhibitor rivaroxaban exerted anti-inflammatory and anti-oxidative stress effects in human AAA lesion, suggesting a role of factor Xa underlying the pathogenesis of AAA [14, 15]. The gene discussed is F10; the disease is triple-A syndrome.